PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
10.21203/rs.3.rs-117463/v12020Association of Cardiovascular Risk Factors and Metabolic Syndrome with Non-alcoholic and Alcoholic Fatty Liver DiseaseA lum Hanhttps://www.researchsquare.com/article/rs-117463/v1, https://www.researchsquare.com/article/rs-117463/v1.html
10.21203/rs.3.rs-86594/v12020Association of Cardiovascular Risk Factors and Metabolic Syndrome with Non-Alcoholic and Alcoholic Fatty Liver DiseaseA Lum Han, Sae-Ron Shinhttps://www.researchsquare.com/article/rs-86594/v1, https://www.researchsquare.com/article/rs-86594/v1.html
Diabetes & Metabolic Syndrome: Clinical Research & Reviews10.1016/j.dsx.2020.05.0192020144695-696From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 yearsMohammad Shafi Kuchay, Anoop Misrahttps://api.elsevier.com/content/article/PII:S1871402120301387?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1871402120301387?httpAccept=text/plain
Metabolic Syndrome10.1007/978-3-319-12125-3_36-120151-21Non-alcoholic Fatty Liver DiseaseElisabeth Smolle, Sonja M. Kessler, Nicole Golob, Johannes Haybaeckhttp://link.springer.com/content/pdf/10.1007/978-3-319-12125-3_36-1
International Journal of Molecular Sciences10.3390/ijms170404902016174490Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver TransplantStefano Gitto, Erica Villahttp://www.mdpi.com/1422-0067/17/4/490/pdf
Experimental and Clinical Gastroenterology10.31146/1682-8658-ecg-183-11-80-10120201831180-101Parallels between non-alcoholic fatty liver disease and non-alcoholic fatty pancreatic disease: looking for points of contact or regard through the lens of metabolic syndromeN. B. Gubergrits, N. V. Byelyayeva, T. L. Mozhynahttps://www.nogr.org/jour/article/viewFile/1481/1414
Diabetology & Metabolic Syndrome10.1186/s13098-021-00644-52021131Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitisSachiko Hattori, Kazuomi Nomoto, Tomohiko Suzuki, Seishu Hayashihttp://link.springer.com/content/pdf/10.1186/s13098-021-00644-5.pdf, http://link.springer.com/article/10.1186/s13098-021-00644-5/fulltext.html, http://link.springer.com/content/pdf/10.1186/s13098-021-00644-5.pdf
Nutrients10.3390/nu50829012013582901-2923Dietary Omega-3 Fatty Acid Deficiency and High Fructose Intake in the Development of Metabolic Syndrome, Brain Metabolic Abnormalities, and Non-Alcoholic Fatty Liver DiseaseArtemis Simopouloshttp://www.mdpi.com/2072-6643/5/8/2901/pdf
Diabetes & Metabolic Syndrome: Clinical Research & Reviews10.1016/j.dsx.2019.07.06020191352957-2960Prevalence and predictors of non-alcoholic fatty liver disease in prediabetesRajesh Rajput, Parul Ahlawathttps://api.elsevier.com/content/article/PII:S1871402119305016?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1871402119305016?httpAccept=text/plain
Liver International10.1111/j.1478-3231.2008.01949.x2009293-12Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment responseZobair M. Younossi, Arthur J. McCulloughhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1478-3231.2008.01949.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2008.01949.x/fullpdf